Epidemiologic Characteristics of Adolescents with COVID-19 Disease with Acute Hypoxemic Respiratory Failure

Table 2

Selected treatment and outcome characteristics of hospitalized patients.

Characteristics	Total (n = 47)
COVID-19 therapy
Hydroxychloroquine, n (%)	8 (17%)
Azithromycin, n (%)	3 (6.4%)
Remdesivir, n (%)	5 (10.6%)
Corticosteroid, n (%)	26 (55.3%)
IL-6 inhibitor, n (%)	1 (2.1%)
Complications
ARDS, n (%)	4 (8.5%)
AKI n (%)	2 (4.2%)
Anoxic cerebral encephalopathy	1 (2.1%)
Outcomes
Status on hospital day 14, n (%)
Discharged (%)	42 (89%)
Mortality, n (%)	0 (0%)